DTL
LRMR icon

Dynamic Technology Lab’s Larimar Therapeutics LRMR Stock Holding History

Dynamic Technology Lab’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-24,009
Closed -$108K – 918
2026
Q1 		$108K Buy
+24,009
New +$96K 0.02% 793
2024
Q3 		– Sell
-16,580
Closed -$120K – 1200
2024
Q2 		$120K Buy
+16,580
New +$127K 0.01% 840
2017
Q4 		– Sell
-1,299
Closed -$55K – 1189
2017
Q3 		$55K Buy
1,299
+443
+52% +$18.4K 0.01% 993
2017
Q2 		$36K Sell
856
-59
-6% -$3.02K 0.01% 965
2017
Q1 		$51K Buy
+915
New +$45.4K 0.01% 919

Other funds holding LRMR

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Dynamic Technology Lab's LRMR Position: Q2 2026 in Review

Dynamic Technology Lab sold out of Larimar Therapeutics (LRMR) in Q2 2026, closing a stake of 24,009 shares — an estimated $108K sold.

Dynamic Technology Lab first reported a position in LRMR in Q1 2017 and held it in 5 quarters. The position peaked at $120K in Q2 2024. 163 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

  • Dynamic Technology Lab reported no remaining Larimar Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Dynamic Technology Lab sold 24,009 Larimar Therapeutics shares in Q2 2026, an estimated $108K.
  • Dynamic Technology Lab first reported a position in Larimar Therapeutics in Q1 2017 and held it in 5 quarters.
  • Dynamic Technology Lab's Larimar Therapeutics position peaked at $120K in Q2 2024.
  • 163 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on Dynamic Technology Lab's 13F filing for Q2 2026, filed 13 Aug 2026.